Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1995 1
1997 1
1998 3
1999 5
2000 1
2001 1
2002 2
2003 4
2004 1
2005 3
2006 5
2007 12
2008 9
2009 8
2010 7
2011 11
2012 17
2013 11
2014 10
2015 11
2016 12
2017 4
2018 7
2019 6
2020 3
2021 6
2022 5
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, Brufsky A, Sardesai SD, Kalinsky K, Zelnak AB, Weaver R, Traina T, Dalenc F, Aftimos P, Lynce F, Diab S, Cortés J, O'Shaughnessy J, Diéras V, Ferrario C, Schmid P, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo MS, Itri LM, Rugo HS; ASCENT Clinical Trial Investigators. Bardia A, et al. N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485. N Engl J Med. 2021. PMID: 33882206 Clinical Trial.
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
Cardio-Oncology.
Rayson D. Rayson D. J Clin Oncol. 2021 Sep 10;39(26):2962-2963. doi: 10.1200/JCO.21.00971. Epub 2021 Jun 8. J Clin Oncol. 2021. PMID: 34101503 No abstract available.
Camouflage.
Rayson D. Rayson D. J Clin Oncol. 2020 Jan 20;38(3):281-282. doi: 10.1200/JCO.19.02007. Epub 2019 Sep 26. J Clin Oncol. 2020. PMID: 31557087 No abstract available.
Sweet Surrender.
Rayson D. Rayson D. J Clin Oncol. 2018 Oct 31:JCO1801212. doi: 10.1200/JCO.18.01212. Online ahead of print. J Clin Oncol. 2018. PMID: 30379625 No abstract available.
On Heartbreak in Oncology.
Rayson D. Rayson D. Curr Oncol Rep. 2019 Jan 25;21(1):7. doi: 10.1007/s11912-019-0755-9. Curr Oncol Rep. 2019. PMID: 30684122 Review. No abstract available.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
ASCO Voices 2020.
Rayson D, Bufill JA, Close J, Cyusa A, Oettel K, Okolo O, Parikh A, Schapira L. Rayson D, et al. J Clin Oncol. 2020 Sep 20;38(27):3231-3232. doi: 10.1200/JCO.20.01584. Epub 2020 Aug 9. J Clin Oncol. 2020. PMID: 32772763 No abstract available.
White Knuckling.
Rayson D. Rayson D. J Clin Oncol. 2016 Apr 20;34(12):1419-20. doi: 10.1200/JCO.2015.65.8419. Epub 2016 Feb 16. J Clin Oncol. 2016. PMID: 26884561 No abstract available.
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. JAMA. 2012 Jul 11;308(2):147-56. doi: 10.1001/jama.2012.7352. JAMA. 2012. PMID: 22782416 Clinical Trial.
154 results